EFFICACY OF COMBINATION SOLID DISPERSION TECHNOLOGY ON DISSOLUTION PERFORMANCE OF NALIDIXIC ACID AND CEFDINIR

Nidhal Khazaal Maraie; Anas Tarik Alhamdany; Ameera Abd Radhi

doi:10.22159/ajpcr.2017.v10i4.16913

Authors

Nidhal Khazaal Maraie Al-Mustansiriyah University/College of pharmacy
Anas Tarik Alhamdany Al-Mustansiriyah University/College of pharmacy
Ameera Abd Radhi Al-Mustansiriyah University/College of pharmacy

DOI:

https://doi.org/10.22159/ajpcr.2017.v10i4.16913

Abstract

Objective: The aim of this study was to formulate a new developed solid dispersion containing fixed dose combination of nalidixic acid and cefdinir (500:300 mg) to improve dissolution rate of poorly soluble drugs via a new mechanism as well as the conventional mechanism of solid dispersion represented by the presence of hydrophilic carrier.

Methods:Through this objective eight newly developed solid dispersion formulas of fixed dose combination of nalidixic acid and cefdinir (500:300 mg) and (polyethylene glycol (PEG) 6000 and poloxamer 188) in different ratio were prepared, in addition to solid dispersion of each drug alone and simple mixture of individual solid dispersion prepared by means of fusion technique. Moreover, solid dispersions beside pure drugs, simple mixture and physical mixture were characterized by dissolution tests, solubility studies, powder x-ray diffractometry (PXRD), differential scanning calorimetry (DSC), FT-IR spectroscopy (FT-IR) and scanning electron microscopy (SEM).

Results: From in vitro dissolution tests, PXRD, DSC, FT-IR, and SEM; it is indicated the presence of a physical complex between cefdinir and nalidixic acid in their solid dispersion containing combination of fixed dose of both drugs. This will affect the crystallinity of the second drug and their dissolution behavior in addition to the conventional mechanism owing to the presence of hydrophilic carrier (poloxamer 188).

Conclusion: I was concluded that the newly prepared formula of solid dispersion containing fixed dose combination of nalidixic acid and cefdinir will be promising for higher dissolution profile than that from solid dispersion of each drug alone or simple mixture of individual solid dispersion of each drug.

Keywords: Nalidixic acid, Cefdinir, Poloxamer 188, Polyethylene glycol 6000, Combinational solid dispersion, Fusion method.

Downloads

Download data is not yet available.

Author Biographies

Nidhal Khazaal Maraie, Al-Mustansiriyah University/College of pharmacy

Department of pharmaceutics

Anas Tarik Alhamdany, Al-Mustansiriyah University/College of pharmacy

Department of pharmaceutics

Ameera Abd Radhi, Al-Mustansiriyah University/College of pharmacy

Department of pharmaceutics

References

Siahi-Shadbad MR, Ghanbarzadeh S, Barzegar-Jalali M, Valizadeh H, Taherpoor A, Mohammadi G, et al. Development and characterization of solid dispersion for dissolution improvement of furosemide by cogrinding method. Adv Pharm Bull 2014;4(4):391-9.

Anshu S, Jain CP. Preparation and characterization of solid dispersions of valsartan with poloxamer 188. Der Pharm Lett 2010;2(2):54-63.

Anju K, Sunil KP, Pragya N. Solubility enhancement studies of solid dispersion. WJPP 2015;4(10):2126-42.

Linda F. Remington, Essentials of Pharmaceutics. 1st ed. USA: Pharmaceutical Press; 2006. p. 238.

Niraj, Jyoti, Srivastava VK, Hemesh S, Narendra S. Solubility and dissolution enhancement of antihypertensive Agent(S) using solid dispersion techniques. Int J Clin Chem Lab Med 2015;1(1):23-8.

Leigh AP, Nemeth MA, Keyserling CH, Hotary LH, Tack KJ. Cefdinir versus cefaclor in the treatment of uncomplicated urinary tract infection. Clin Ther 2000;22(7):818-25.

Taori A, Nema R, Kohli DV, Uppadhyay RK. Nalidixic acid prodrugs: Amides from amino acid ester and nalidixic acid. Arch Pharm Res 1991;14(1):48-51.

Nazik AE, Shalaby AA, Abd Bl-Khalek MM. Dissolution of nalidixic acid solid dispersions: Systems of NAL-inclusion and linear polymeric compounds. Drug Dev Ind Pharm 2008;9(6):1031-45.

Suman T, Muzammil AS, Ramesh B, Kishan V. Development and in vivo evaluation of cefdinir nanosuspension for improved oral bioavailability. Int J Pharm Sci Nanotechnol 2014;7(3):2553-60.

Thirupathi A, Reddy A, Narayana AD, Meshram S, Sampathi S. Solid state characterization of the polymorphic changes in candesartan cilexetil solid dispersion with poly ethylene glycol 8000. IJPSR 2014;6(1):27-32.

Rao BR, Chandrasekhar B. Preparation and characterization of pioglitazone HCl solid inclusion complex a solubility enhancement technique. Int J Biopharm 2014;5(3):180-3.

Kour P, Kumar M, Kataria MK, Bilandi A. Dissolution rate enhancement of pioglitazone by solid dispersion technique. IAJPR 2015;5(7):2664-81.

Mallick S, Sahu A, Pal K. Dissolution behaviour of nalidixic acid solid dispersions using water soluble dispersion carriers. Acta Pol Pharm 2004;61(1):21-30.

Japanese Pharmacopoeia. 17th ed. Japan: Pharmaceuticals and Medical Devices Agency under the Authority of the Ministry of Health, Labour and Welfare; 2016.

Mohan A, Madhavi M, Swetha G, Jyosthna P. Preparation, in vitro and in vivo characterization of solid dispersions of lamotrigine using solvent evaporation technique. IOSR J Pharm 2015;5(1):54-9.

Yadav B, Tanwar YS. Development, characterization and in vitro evaluation of flurbiprofen solid dispersions using polyethylene glycols as carrier. J Appl Pharm Sci 2016;6(4):60-6.

Gavali RD, Patil SS. Enhancement of dissolution profile by preparing solid dispersion using spray drying method. Der Pharm Lett 2016;8(5):362-72.

Balata G, Mahdi M, Bakera RA. Improvement of solubility and dissolution properties of ketoconazole by solid dispersions and inclusion complexes. Asian J Pharm Sci 2010;5(1):1-12.

Howlader SI, Chakrabarty JK, Faisal KS, Kumar U, Sarkar R, Khan MF. Enhancing dissolution profile of diazepam using hydrophilic polymers by solid dispersion technique. Int Curr Pharm J 2012;1(12):423-30.

Essa EA, Dwaikat M. Enhancement of simvastatin dissolution by surface solid dispersion: Effect of carriers and wetting agents. J Appl Pharm Sci 2015;5(1):46-53.

Deshmukh KR, Jain SK. Development of aceclofenac mouth dissolving tablets using solid dispersion technique: In-vitro evaluation. IJPER 2012;46(2):97-104.

AbdAlaziz DM, Sammour OA, Elshamy AA, Neseem DI. Formulation and evaluation of binary and ternary solid dispersions of domperidone by solvent evaporation method. Afr J Pharm Pharmacol 2014;8(3):66-80.

Panneerselvam M, Natrajan R, Selvaraj S, Rajendran NN. A novel drug-drug solid dispersion of hydrochlorothiazide - losartan potassium. IJPBS 2010;1(4):68-80.

Manvi P, Narendra P, Bhaskar VH. Preparation, characterization and in

Fig. 10: Scanning electron microscopy for (a) pure cefdinir powder; (b) pure nalidixic powder; (c) poloxamer 188; (d) SD7 and (e) simple mixture of individual SD (SMSD) vitro evaluation of repaglinide binary solid dispersion with hydrophilic polymers. Int J Drug Dev Res 2011;3(1):107-17.

Jain S, Mishra A, Garg G, Modi RK. Formulation and characterization of fast disintegrating tablets containing cefdinir solid dispersion. Int J Pharm Life Sci 2012;3(12):2190-9.

Mustafa RA, Nidhal KM, Ashour HD. Loading of clarithromycin and paclitaxel on synthesized CDS/NIO nanoparticles as promising nano carriers. Int J Pharm Pharm Sci 2016;8(5):322-33.

Shahad M, Nidhal M, Ashour HD. Preparation and comparative evaluation of Fe+2/Fe+3 and Mg+2/Fe+3 LDHs as promising nano carriers for class II and class IV drugs. J Nat Sci Res 2015;5(14):126-37.

Monica R, Yogesh M, Kaushik T, Sucheta B. Dissolution improvement of simvastatin by surface solid dispersion technology. Dissolution Technol 2010;17(2):27-34.

Marco VC, AndrÃ©a CL, Marta MV, Maria OP, FÃ¡bio CP, Liliane NP, et al. Development and evaluation of praziquantel solid dispersions in sodium starch glycolate. Trop J Pharm Res 2013;12(2):163-8.

Kumar P, Kumar S, Kumar A, Chander M. Physicochemical characterization of solid dispersions of cefdinir with PVP K-30 and PEG 4000. Int J Pharm Sci Nano 2010;3(2):948-56.

Anmar AI, Daniela M, Victor C, Valintina A. Preparation and evaluation of meloxicam solid dispersion by melting method. Farmacia 2013;61(6):1216-32.

Shah S, Joshi S, Lin S, Madan PL. Preparation and characterization of spironolactone solid dispersions using hydrophilic carriers. AJPS 2012;7(1):40-9.

Roni MA, Dipu MH, Kibria G, Rahman H, Rony MD, Jalil RU. Dissolution enhancement of poorly soluble carbamazepine by using polymeric solid dispersions. IJPSR 2011;2(1):49-57.

Gorniak A, Karolewicz B, Czapor-Irzabek H, Gladysz O. A physicochemical and dissolution study of ketoconazole - pluronic F127 solid dispersions. Farmacia 2016;64(2):244-51.

Muthu S, Elamurugu PE, Yusuf E. Density functional theory and abinitio studies of vibrational spectra of nalidixic acid. IAPS 2011;15(2):205-22.

Bansal S, Aggarwal G, Chandel P, Harikumar SL. Design and development of cefdinir niosomes for oral delivery. J Pharm Bioallied Sci 2013;5(4):318-25.

Sharma A, Chandra PJ, Yuveraj ST. Preparation and characterization of solid dispersions of carvidolol with poloxamer 188. J Chil Chem Soc 2013;58(1):1553-7.

Margrit A, Azza H, Hanas EN, Fakhr-Eldin G. Enhancing oral bioavailability of carvidolol using solid dispersion technique. Int J Pharm Pharm Sci 2016;8(7):193-9.

Krishnamoorthy V, Nagalingam A, Priya Ranjan Prasad V, Parameshwaran S, George N, Kaliyan P. Characterization of olanzapine-solid dispersions. Iran J Pharm Res 2011;10(1):13-24.

Vivek S, Swati M. Formulation of alternative dosage from for cephalosporin (CEFDINIR). Asian J Biomed Pharm Sci 2014;4(33):29-42.

Pina MF, Zhao M, Pinto JF, Sousa JJ, Craig DQ. The influence of drug physical state on the dissolution enhancement of solid dispersions prepared via hot-melt extrusion: A case study using olanzapine. J Pharm Sci 2014;103(4):1214-23.